A selective approach to patients with thyroid nodules, in order to differentiate between negative findings and uncertain or positive results requiring surgery, has been outlined. Fine needle aspiration biopsy (FNAB) is the most reliable and cost-effective technique currently available to distinguish benign from malignant thyroid disease. In those lesions diagnosed by FNAB as 'follicular lesions', radionuclide scanning, serum calcitonin and CEA determination, color doppler ultrasonography and the response to TSH suppressive therapy may be of assistance. Despite such screening procedures, the majority of follicular lesions remain indeterminate, and surgery is therefore necessary before a correct diagnosis can be made. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Pelizzo M.R., Toniato A., Piotto A., Bernante P., Bernardi C., Pagetta C. (2000). Preoperative assessment of thyroid nodules: The surgeon's point of view. BIOMÉDECINE & PHARMACOTHÉRAPIE, 54(6), 327-329 [10.1016/S0753-3322(00)80057-8].

Preoperative assessment of thyroid nodules: The surgeon's point of view

Bernante P.;
2000

Abstract

A selective approach to patients with thyroid nodules, in order to differentiate between negative findings and uncertain or positive results requiring surgery, has been outlined. Fine needle aspiration biopsy (FNAB) is the most reliable and cost-effective technique currently available to distinguish benign from malignant thyroid disease. In those lesions diagnosed by FNAB as 'follicular lesions', radionuclide scanning, serum calcitonin and CEA determination, color doppler ultrasonography and the response to TSH suppressive therapy may be of assistance. Despite such screening procedures, the majority of follicular lesions remain indeterminate, and surgery is therefore necessary before a correct diagnosis can be made. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
2000
Pelizzo M.R., Toniato A., Piotto A., Bernante P., Bernardi C., Pagetta C. (2000). Preoperative assessment of thyroid nodules: The surgeon's point of view. BIOMÉDECINE & PHARMACOTHÉRAPIE, 54(6), 327-329 [10.1016/S0753-3322(00)80057-8].
Pelizzo M.R.; Toniato A.; Piotto A.; Bernante P.; Bernardi C.; Pagetta C.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/914492
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact